{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:44:20Z","timestamp":1776487460341,"version":"3.51.2"},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,4,17]]},"DOI":"10.1248\/bpb.b26-00033","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:09:57Z","timestamp":1776377397000},"page":"732-737","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical Localization of Sotorasib\u2013Protein Conjugates in the Rat Gastrointestinal Tract"],"prefix":"10.1248","volume":"49","author":[{"given":"Tetsuya","family":"Saita","sequence":"first","affiliation":[{"name":"Department of Biotechnology and Life Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyabi","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Life Sciences, Sojo University, 4\u201322\u20131 Ikeda, Nishi-ku, Kumamoto 860\u20130082, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hong DS, Fakih MG, Strickler JH, <i>et al<\/i>. KRAS<sup>G12C<\/sup> inhibition with sotorasib in advanced solid tumors. <i>N. Engl. J. Med.<\/i>, <b>383<\/b>, 1207\u20131217 (2020).","DOI":"10.1056\/NEJMoa1917239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Skoulidis F, Li BT, Dy GK, <i>et al<\/i>. Sotorasib for lung cancers with <i>KRAS<\/i> p.G12C mutation. <i>N. Engl. J. Med.<\/i>, <b>384<\/b>, 2371\u20132381 (2021).","DOI":"10.1056\/NEJMoa2103695"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee A. Sotorasib: a review in <i>KRAS G12C<\/i> mutation-positive non-small cell lung cancer. <i>Target. Oncol.<\/i>, <b>17<\/b>, 727\u2013733 (2022).","DOI":"10.1007\/s11523-022-00922-w"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Skoulidis F, Li BT, Hochmair M, <i>et al<\/i>. Pooled safety analysis and management of sotorasib-related adverse events in <i>KRAS<\/i> G12C-mutated advanced non-small cell lung cancer. <i>Oncologist<\/i>, <b>30<\/b>, oyae356 (2025).","DOI":"10.1093\/oncolo\/oyae356"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ishida K, Werner JA, Davies R, Fan F, Thomas B, Wahlstrom J, Lipford JR, Monticello T. Nonclinical safety profile of sotorasib, a KRAS<sup>G12C<\/sup>-specific covalent inhibitor for the treatment of <i>KRAS p.G12C<\/i>-mutated cancer. <i>Int. J. Toxicol.<\/i>, <b>40<\/b>, 427\u2013441 (2021).","DOI":"10.1177\/10915818211022965"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zhang J, Li J, Cheng M, Zhou H, Zhang X, Yan H, Xu Z, Yang B, He Q, Gao Z, Chen X, Luo P. Off-target engagement of sotorasib with PPAR\u03b3 <i>via<\/i> FABP4: a novel mechanism driving interstitial lung disease. <i>Cell Commun. Signal.<\/i>, <b>23<\/b>, 416 (2025).","DOI":"10.1186\/s12964-025-02425-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamamoto Y, Saita T, Yamamoto Y, Sogawa R, Kimura S, Narisawa Y, Kimura S, Shin M. Immunohistochemical localization of afatinib in male rat intestines and skin after its oral administration. <i>Acta Histochem.<\/i>, <b>121<\/b>, 151439 (2019).","DOI":"10.1016\/j.acthis.2019.09.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yamamoto Y, Saita T, Oka A, Kataoka H, Shin M. Localization and accumulation studies of dacomitinib in rat intestines and skin by immunohistochemistry. <i>Acta Histochem. Cytochem.<\/i>, <b>52<\/b>, 101\u2013106 (2019).","DOI":"10.1267\/ahc.19031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamamoto Y, Saita T, Kataoka H, Sogawa R, Kimura S, Kimura S, Shimanoe C, Shin M. Localization of sites of osimertinib action in rat intestine, skin, and lung by immunohistochemistry. <i>Acta Histochem. Cytochem.<\/i>, <b>56<\/b>, 145\u2013151 (2023).","DOI":"10.1267\/ahc.23-00055"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kataoka H, Saita T, Yamamoto Y, Kimura S, Sogawa R, Shimanoe C. Immunohistochemical study of the localization of ibrutinib-protein conjugates in the rat gastrointestinal tract. <i>Acta Histochem. Cytochem.<\/i>, <b>58<\/b>, 93\u2013100 (2025).","DOI":"10.1267\/ahc.24-00053"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Habeeb AF. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. <i>Anal. Biochem.<\/i>, <b>14<\/b>, 328\u2013336 (1966).","DOI":"10.1016\/0003-2697(66)90275-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kataoka H, Saita T, Oka A, Yamada M, Shin M. An indirect competitive enzyme-linked immunosorbent assay for the determination of brigatinib and gilteritinib using a specific polyclonal antibody. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 904\u2013909 (2022).","DOI":"10.1248\/bpb.b22-00166"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Fujiwara K, Shin M, Yoshizaki Y, Miyazaki T, Saita T. Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney. <i>J. Mol. Histol.<\/i>, <b>42<\/b>, 589\u2013596 (2011).","DOI":"10.1007\/s10735-011-9365-z"},{"key":"14","unstructured":"14) Science Council of Japan. 2006. \u201cGuidelines for Proper Conduct of Animal Experiments.\u201d: &lt;https:\/\/www.scj.go.jp\/ja\/info\/kohyo\/pdf\/kohyo-20-k16-2e.pdf&gt;, accessed 17 March, 2026."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shin M, Yamamoto Y, Kataoka H, Saita T. Development of immunohistochemistry for detecting fluvoxamine in rat tissues using newly prepared monoclonal antibody: its precise localization in small intestine, kidney, and liver of rats. <i>Med. Mol. Morphol.<\/i>, <b>56<\/b>, 28\u201337 (2023).","DOI":"10.1007\/s00795-022-00337-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mamatha Jyothi RS, Sripathi MP, Thirupathi P. Recent advances in base-assisted Michael addition reactions. <i>Curr. Org. Chem.<\/i>, <b>26<\/b>, 1264\u20131293 (2022).","DOI":"10.2174\/1385272826666220827095110"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Du P, Liu L, Hu T, An Z. Integrative analysis of pharmacokinetic and metabolomic profiles for predicting metabolic phenotype and drug exposure caused by sotorasib in rats. <i>Front. Oncol.<\/i>, <b>12<\/b>, 778035 (2022).","DOI":"10.3389\/fonc.2022.778035"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Vuu I, Dahal UP, Wang Z, Shen X, Rodgers J, Wahlstrom J, Houk B. Absorption, metabolism and excretion of [<sup>14<\/sup>C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate. <i>Cancer Chemother. Pharmacol.<\/i>, <b>90<\/b>, 357\u2013367 (2022).","DOI":"10.1007\/s00280-022-04470-y"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Spaan CN, de Boer RJ, Smit WL, van der Meer JHM, van Roest M, Vermeulen JLM, Koelink PJ, Becker MAJ, Go S, Silva J, Faller WJ, van den Brink GR, Muncan V, Heijmans J. Grp78 is required for intestinal KRAS-dependent glycolysis, proliferation and adenomagenesis. <i>Life Sci. Alliance<\/i>, <b>6<\/b>, e202301912 (2023).","DOI":"10.26508\/lsa.202301912"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Khoramjoo SM, Kazemifard N, Baradaran Ghavami S, Farmani M, Shahrokh S, Asadzadeh Aghdaei H, Sherkat G, Zali MR. Overview of three proliferation pathways (Wnt, Notch, and Hippo) in intestine and immune system and their role in inflammatory bowel diseases (IBDs). <i>Front. Med.<\/i>, <b>9<\/b>, 865131 (2022).","DOI":"10.3389\/fmed.2022.865131"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Abud HE, Chan WH, Jard\u00e9 T. Source and impact of the EGF family of ligands on intestinal stem cells. <i>Front. Cell Dev. Biol.<\/i>, <b>9<\/b>, 685665 (2021).","DOI":"10.3389\/fcell.2021.685665"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b26-00033\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:03:51Z","timestamp":1776485031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/4\/49_b26-00033\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00033","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"article-number":"b26-00033"}}